Improvement of mouse β-thalassemia by electrotransfer of erythropoietin cDNA
Authors:
- Emmanuel PayenEPEmmanuel Payen
- Mickaël BettanMBMickaël Bettan
- Philippe Rouyer-FessardPRPhilippe Rouyer-Fessard
- Yves BeuzardYBYves Beuzard
- Daniel SchermanDSDaniel Scherman
- 1 March 2001
- journal article
- Published by Elsevier in Experimental Hematology
- Vol. 29 (3) , 295-300
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Modulation of transduced erythropoietin expression by ironExperimental Hematology, 2000
- Continuous Erythropoietin Delivery by Muscle-Targeted Gene Transfer Using in Vivo ElectroporationHuman Gene Therapy, 2000
- Avoiding Transfusion in Head and Neck Surgery: Feasibility Study of ErythropoietinThe Laryngoscope, 2000
- Improvement of mouse β-thalassemia upon erythropoietin delivery by encapsulated myoblastsGene Therapy, 1999
- Cost Effectiveness, Quality-Adjusted Life-Years and Supportive CarePharmacoEconomics, 1999
- Removal of erythrocyte membrane iron in vivo ameliorates the pathobiology of murine thalassemia.Journal of Clinical Investigation, 1997
- Improvement of mouse β thalassaemia by hydroxyureaBritish Journal of Haematology, 1993
- Stimulation of Fetal Hemoglobin Synthesis by Erythropoietin in BaboonsNew England Journal of Medicine, 1987
- Correction of Murine β-Thalassemia by Gene Transfer into the Germ LineScience, 1986
- Attempts at Gene Therapy in β‐Thalassemic MiceAnnals of the New York Academy of Sciences, 1985